The 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2016) was attended by more than 2,600 participants from 90 different countries. The Conference is considered to be the main networking event in the field, attracting an international audience of researchers and clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers as well as general & family medicine practitioners.
The 9th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD 2016) was attended by more than 2,600 participants from 90 different countries. The Conference is considered to be the main networking event in the field, attracting an international audience of researchers and clinicians from the fields of diabetes, endocrinology and metabolism, diabetes technology developers as well as general & family medicine practitioners.
interviste
Tissue Engineering and Cellular Replacement in Diabetes Treatment
Ingegneria tissutale e ricambio cellulare nel trattamento del diabete
Is Type 1 Diabetes Mellitus an Autoimmune Disease?
Big data open a new era in diabetes management
Artificial pancreas systems: towards fully automatic control
Diabete gestazionale: conseguenze sul feto e nel corso della vita
Is the gut the "sweet spot" for the treatment of type 2 diabetes?
E' l'intestino il punto più adatto per il trattamento del diabete di tipo 2?
Reimbursement policies for Continuous Glucose Monitoring
Continuous, non-invasive blood glucose measurement
I vantaggi della misurazione glicemica continua e non invasiva
Glucose levels and nutrition tailored to the microbiome
Impact of exercise on glucose control in type 1 diabetes
Remotely managing CGM technology with smartphones
The practical use of retrospective CGM
associazioni pazienti
Il monitoraggio continuo è la coscienza elettronica del diabetico
Il ruolo del paziente-tutor nella diffusione dell'uso dei nuovi device
Con i sistemi di controllo continuo non invasivo migliora l'aderenza alla terapia
